Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Early 3+3 Trial Dose-Escalation Phase I Clinical Trial Design and Suitability for Immune Checkpoint Inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 15, 2020
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma.
Journal: British journal of haematology
Published: August 26, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026